ストックスクリーナーアプリを入手
209.13
1.59%
-3.37
プレマーケット:
211.79
2.66
+1.27%
前日終値:
$212.50
開ける：
$212.09
24時間の取引高:
954.71K
Relative Volume:
0.98
時価総額：
$15.37B
収益：
$2.88B
当期純損益:
$499.60M
株価収益率:
31.03
EPS:
6.74
ネットキャッシュフロー:
$321.60M
1週間 パフォーマンス:
+2.75%
1か月 パフォーマンス:
-9.12%
6か月 パフォーマンス:
-27.63%
1年 パフォーマンス:
-44.89%
1日の値動き範囲:
$207.52
$214.62
1週間の範囲:
$195.04
$214.62
52週間の値動き範囲:
$187.43
$394.42
West Pharmaceutical Services Inc Stock (WST) Company Profile
名前
West Pharmaceutical Services Inc
セクター
電話
(610) 594-2900
住所
530 HERMAN O. WEST DRIVE, EXTON, PA
WST を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
209.13 | 15.37B | 2.88B | 499.60M | 321.60M | 6.74 |
|
ISRG
Intuitive Surgical Inc
|
481.34 | 172.45B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
200.40 | 57.54B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.05 | 45.53B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
211.49 | 31.06B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
78.23 | 15.58B | 3.90B | 392.30M | 288.10M | 1.95 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-18 | 開始されました | Evercore ISI | Outperform |
| 2025-02-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 開始されました | Citigroup | Buy |
| 2024-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2024-12-12 | アップグレード | UBS | Neutral → Buy |
| 2024-02-07 | アップグレード | Jefferies | Hold → Buy |
| 2023-06-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-04-11 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Hold |
| 2022-11-30 | 開始されました | UBS | Neutral |
| 2022-10-28 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 開始されました | Stephens | Equal-Weight |
| 2020-07-21 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-04-24 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | ダウングレード | Jefferies | Buy → Hold |
| 2019-04-23 | 開始されました | William Blair | Outperform |
| 2018-04-25 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 開始されました | Goldman | Neutral |
| 2017-10-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 開始されました | Stephens | Equal-Weight |
| 2017-09-15 | アップグレード | Jefferies | Hold → Buy |
| 2016-10-28 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 開始されました | Wells Fargo | Outperform |
| 2010-05-14 | 繰り返されました | UBS | Neutral |
| 2010-02-23 | 開始されました | Jefferies & Co | Buy |
| 2008-12-19 | 開始されました | UBS | Neutral |
すべてを表示
West Pharmaceutical Services Inc (WST) 最新ニュース
Agree To Purchase West Pharmaceutical Services At $180, Earn 11.2% Annualized Using Options - Nasdaq
Press Release Distribution & PR Platform - ACCESS Newswire
Fill Finish Manufacturing Market to Witness Upsurge in Growth - openPR.com
West Pharmaceutical price target lowered to $280 from $285 at BofA - Yahoo Finance
UGI Corporation to Announce Q2 2025 Results with Live Webcast - MyChesCo
West Pharmaceutical Announces Departure of Senior Executive - TipRanks
BofA Securities Cuts West Pharmaceutical Services Price Target to $280 From $285, Maintains Neutral Rating - MarketScreener
West Pharmaceutical Services to Announce Q1 2025 Results with Live Webcast and Q&A Session - MSN
Zacks Research Issues Positive Outlook for WST Earnings - Defense World
Wellington Management Group LLP Buys 99 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Services Earnings Preview: What to Expect - MSN
West Pharmaceutical Services, Inc.'s (NYSE:WST) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Zacks Research Analysts Reduce Earnings Estimates for WST - Defense World
Penn College lab named in honor of West Pharmaceutical Services - Penn State University
College lab named in honor of West Pharmaceutical Services - Pennsylvania College of Technology
WST ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of West Pharmaceutical Services, Inc. Shareholders Who Lost Money - ACCESS Newswire
The Latest Breaking News on West Pharmaceutical Services Earnings Preview: What to Expect - Inkl
West Pharmaceutical Services Earnings Preview: What To Expect - Barchart.com
West to Host First-Quarter 2025 Conference Call - The Malaysian Reserve
Mark Your Calendar: West Pharmaceutical Announces Critical Q1 2025 Earnings Date - Stock Titan
Will Weakness in West Pharmaceutical Services, Inc.'s (NYSE:WST) Stock Prove Temporary Given Strong Fundamentals? - simplywall.st
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsWST - ACCESS Newswire
West Pharmaceutical stock hits 52-week low at $196.78 - Investing.com Australia
West Pharmaceutical stock hits 52-week low at $196.78 By Investing.com - Investing.com India
Analysis of China-to-West pharmaceutical licensing deals in 2024 - Nature
ATTENTION WST SHAREHOLDERS: Investors who Lost Money on West Pharmaceutical Services, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation - ACCESS Newswire
Trump administration shutters DC foreign policy think tank Wilson Center - MarketScreener
Teacher Retirement System of Texas Takes Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsWST - ACCESS Newswire
National Wealth Management Group LLC Makes New $706,000 Investment in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Pharmaceutical Testing Services Market Set to Witness - openPR.com
Delcath Systems (NASDAQ:DCTH) and West Pharmaceutical Services (NYSE:WST) Critical Survey - Defense World
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment - ACCESS Newswire
Commonwealth Equity Services LLC Trims Stake in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
How Is The Market Feeling About West Pharmaceutical Servs? - Benzinga
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks - Yahoo Finance
West Pharmaceutical Services, Inc. (NYSE:WST) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
West Pharmaceutical Services: Bylaw Changes and Share Price Dynamics - AInvest
West Pharmaceutical Services (NYSE:WST) Proposes Bylaw Changes; Share Price Remains Flat - Yahoo Finance
Is West Pharmaceutical Services Stock Underperforming the S&P 500? - Nasdaq
Is West Pharmaceutical Services Stock Underperforming The S&P 500? - Barchart.com
West Pharmaceutical at KeyBanc Forum: Strategic Growth Amid Challenges - Investing.com
West Pharmaceutical at KeyBanc Forum: Strategic Growth Amid Challenges By Investing.com - Investing.com UK
UBS maintains Buy on West Pharma, reiterates $285 target By Investing.com - Investing.com Canada
UBS maintains Buy on West Pharma, reiterates $285 target - Investing.com
Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- WST - ACCESS Newswire
This West Pharmaceutical Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
West Pharmaceutical Services Inc (WST) 財務データ
収益
当期純利益
現金流量
EPS
0.55%
2.35%
大文字化:
|
ボリューム (24 時間):